Arden Trust CO Guardant Health, Inc. Transaction History

Arden Trust CO

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 20, 2022	SELL	$43.66 - $61.0 $5,763 - $8,052	-132 Reduced 1.73%	7,515 $404,000
Q2 2022 Jul 12, 2022	SELL	$28.82 - $77.35 $634 - $1,701	-22 Reduced 0.29%	7,647 $309,000
Q1 2022 Apr 11, 2022	SELL	$48.25 - $100.49 $31,459 - $65,519	-652 Reduced 7.84%	7,669 $508,000
Q4 2021 Jan 24, 2022	SELL	$88.71 - $120.43 $11,177 - $15,174	-126 Reduced 1.49%	8,321 $832,000
Q3 2021 Oct 12, 2021	BUY	$98.77 - $132.17 $11,951 - $15,992	121 Added 1.45%	8,447 $1.06 Million
Q2 2021 Jul 19, 2021	BUY	$109.77 - $165.68 $21,514 - $32,473	196 Added 2.41%	8,326 $1.03 Million
Q1 2021 Apr 23, 2021	SELL	$127.04 - $179.1 $82,067 - $115,698	-646 Reduced 7.36%	8,130 $1.24 Million
Q4 2020 Jan 15, 2021	SELL	$99.96 - $135.93 $5,897 - $8,019	-59 Reduced 0.67%	8,776 $1.13 Million
Q3 2020 Oct 15, 2020	SELL	$80.32 - $111.8 $169,796 - $236,345	-2,114 Reduced 19.31%	8,835 $987,000
Q2 2020 Jul 09, 2020	BUY	$60.49 - $97.5 $214,134 - $345,150	3,540 Added 47.78%	10,949 $888,000
Q1 2020 Apr 16, 2020	BUY	$59.04 - $88.81 $437,427 - $657,993	7,409 New	7,409 $515,000

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.64B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Arden Trust CO, based on Form 13F filings with the SEC.

Stay updated on Arden Trust CO with notifications on news.